Real-time enrollment status for this acute lymphoblastic leukemia clinical trial
Current Status
Recruiting
Checked: October 19, 2026 at 2:20 AM UTC
| NCT Number | NCT05519579 |
| Recruiting Status | Recruiting |
| Condition | Acute Lymphoblastic Leukemia |
| Phase | PHASE2 |
| Target Enrollment | 20 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Northside Hospital, Inc. |
| Last Updated on CT.gov | October 14, 2026 (5 days ago) |
As of October 19, 2026: Clinical trial NCT05519579 is currently recruiting participants. This phase2 study for acute lymphoblastic leukemia is actively seeking new participants at 1 location across the United States. The study is sponsored by Northside Hospital, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05519579 is actively recruiting participants as of October 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05519579 was last updated 5 days ago (October 14, 2026). HelloStudys verifies this status automatically.